Comparison of methods for the biomonitoring of nurses handling antitumor drugs
- PMID: 2047815
- DOI: 10.5271/sjweh.1724
Comparison of methods for the biomonitoring of nurses handling antitumor drugs
Abstract
Urinary mutagenicity, thioethers in urine, and sister chromatid exchanges and micronuclei in peripheral lymphocytes were determined for 60 nurses handling cytostatic drugs and 60 referents matched for sex, age, and smoking habits. Safety hoods were used by most of the nurses. The exposed nurses had more sister chromatid exchanges and higher urinary mutagenicity, as measured by Salmonella typhimurium TA 98, than the referents. There were no differences in the other tests. No dose-response relationship was established for any parameter. It was concluded that urinary mutagenicity with the Salmonella strain is the most sensitive test for monitoring nurses handling cytostatic drugs. Determining sister chromatid exchanges may also be a viable test, but it has the drawback of uncertainty as to whether the changes are attributable to present or past exposure. Only comparisons of rather large groups are useful, and a study design requiring matched referents would seem to be optimal.
Similar articles
-
Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs.Drug Saf. 1999 Apr;20(4):347-59. doi: 10.2165/00002018-199920040-00004. Drug Saf. 1999. PMID: 10230582 Review.
-
Sister-chromatid exchanges in lymphocytes and mutagenicity in urine of nurses handling cytostatic drugs.Mutat Res. 1985 Aug-Sep;157(2-3):235-40. doi: 10.1016/0165-1218(85)90121-1. Mutat Res. 1985. PMID: 4022044
-
Urine mutagenicity, chromosomal abnormalities and sister chromatid exchanges in lymphocytes of nurses handling cytostatic drugs.Int Arch Occup Environ Health. 1986;57(3):195-205. doi: 10.1007/BF00405788. Int Arch Occup Environ Health. 1986. PMID: 3957439
-
Comparison of three assays for genetic effects of antineoplastic drugs on cancer patients and their nurses.Environ Mol Mutagen. 1990;15(2):83-92. doi: 10.1002/em.2850150205. Environ Mol Mutagen. 1990. PMID: 2407531
-
Monitoring occupational exposure to cancer chemotherapy drugs.Am J Health Syst Pharm. 1996 Nov 15;53(22):2713-23. doi: 10.1093/ajhp/53.22.2713. Am J Health Syst Pharm. 1996. PMID: 8931813 Review.
Cited by
-
Handling of cytotoxic drugs by healthcare workers. A review of the risks of exposure.Drug Saf. 1992 Sep-Oct;7(5):374-80. doi: 10.2165/00002018-199207050-00005. Drug Saf. 1992. PMID: 1418694 Review.
-
Biological monitoring of cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs.Occup Environ Med. 1994 Apr;51(4):229-33. doi: 10.1136/oem.51.4.229. Occup Environ Med. 1994. PMID: 8199663 Free PMC article.
-
Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs.Drug Saf. 1999 Apr;20(4):347-59. doi: 10.2165/00002018-199920040-00004. Drug Saf. 1999. PMID: 10230582 Review.
-
Human effect monitoring in cases of occupational exposure to antineoplastic drugs: a method comparison.Occup Environ Med. 1998 Mar;55(3):145-9. doi: 10.1136/oem.55.3.145. Occup Environ Med. 1998. PMID: 9624264 Free PMC article.
-
Leukaemia and reproductive outcome among nurses handling antineoplastic drugs.Br J Ind Med. 1992 Dec;49(12):855-61. doi: 10.1136/oem.49.12.855. Br J Ind Med. 1992. PMID: 1472444 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous